GW Pharmaceuticals PLC (NASDAQ: GWPH) Market cap = over $3 billion
GW Pharma is a biopharmaceutical company involved with commercialization of cannabis related therapeutics.
They have a cannabidiol treatment for rare forms of epilepsy and have received orphan drug and fast-track designation from the U.S. Food and Drug Administration in the USA. Their drug is called Epidiolex.
It has done well in trials but there is competition in this niche for the company.
GW Pharmaceuticals hasn’t set up their page yet so the information is limited. To set up an Investors Corner’ profile page on MarijuanaWerx.com or to get information, please contact us though the contact page on this website. Put your company’s profile in front of very high-quality visitors today! Display banner advertising is also available